Reaction

Cervical Spinal Stenosis reporting signals

Last recalculated 2026-09-14T18:28:35.993900+00:00 · 1,707 reports · 58 co-occurring drugs

As of the last recalculation, Cervical Spinal Stenosis appears in 1,707 FAERS reports alongside 58 co-occurring drug terms. The strongest observed disproportionality signal is MODAFINIL (PRR 15.4).

Important: FAERS is a spontaneous, voluntary, unverified reporting system. PRR and ROR identify reporting patterns for investigation; they are not incidence rates and do not establish causation.

Drug	Co-reports	PRR	ROR
Modafinil	40	15.4	15.5
Methocarbamol	27	14.7	14.7
Cimetidine	11	14.0	14.0
Standardized Senna Concentrate	14	13.7	13.7
Tolterodine Tartrate	10	13.7	13.7
Elvitegravir, Cobicistat, Emtricitabine, And Tenofovir Disoproxil Fumarate	10	13.6	13.6
Alendronate Sodium	106	13.6	13.6
Butalbital, Acetaminophen, And Caffeine	11	12.7	12.7
Methocarbamol Tablets	17	12.5	12.5
Chlorhexidine Gluconate	9	12.1	12.1
Meperidine Hydrochloride	9	12.0	12.0
Tizanidine Hydrochloride	17	11.6	11.6
Cyclobenzaprine	46	11.5	11.5
Thyroid, Porcine	10	11.5	11.5
Elvitegravir, Cobicistat, Emtricitabine, And Tenofovir Alafenamide	9	11.0	11.0
Cephalexin	19	10.8	10.8
Docusate Sodium - Sennosides	28	10.7	10.8
Dronabinol	7	10.7	10.7
Diphenoxylate Hydrochloride And Atropine Sulfate	11	9.8	9.9
Carisoprodol	15	9.7	9.7
Terazosin Hydrochloride	7	9.6	9.6
Lubiprostone	7	9.1	9.1
Meclizine Hcl 12.5Mg	10	9.0	9.0
Meclizine Hcl 25Mg	10	9.0	9.0
Meclizine Hcl 12.5 Mg	10	9.0	9.0
Meclizine Hcl 25 Mg	10	9.0	9.0
Tizanidine	17	8.8	8.8
Dextroamphetamine Saccharate, Amphetamine Aspartate, Dextroamphetamine Sulfate, And Amphetamine Sulfate	25	8.7	8.8
Emtricitabine And Tenofovir Alafenamide	8	8.6	8.6
Salmeterol Xinafoate	6	8.5	8.5
Baclofen	56	8.2	8.2
Loratadine And Pseudoephedrine Sulfate	5	7.7	7.7
Armodafinil	13	7.6	7.6
Dextroamphetamine Sulfate, Dextroamphetamine Saccharate, Amphetamine Sulfate And Amphetamine Aspartate	25	7.4	7.4
Sodium Oxybate	38	7.2	7.2
Bictegravir Sodium, Emtricitabine, And Tenofovir Alafenamide Fumarate	10	6.8	6.8
Cladribine	5	6.4	6.4
Eszopiclone	13	6.3	6.3
Memantine	7	6.3	6.3
Memantine Hydrochloride	7	6.3	6.3
Interferon Beta-1A	92	6.1	6.1
Rimegepant Sulfate	6	5.8	5.8
Peginterferon Beta-1A	6	5.6	5.6
Tofacitinib Citrate	6	5.6	5.6
Emtricitabine And Tenofovir Disoproxil Fumarate	20	5.4	5.4
Oxycodone And Acetaminophen	10	5.3	5.3
Dalfampridine	29	5.0	5.0
Ocrelizumab	25	5.0	5.0
Fingolimod Hcl	32	4.6	4.6
Diroximel Fumarate	4	4.1	4.1
Natalizumab	58	4.0	4.0
Botulinum Toxin Type A	4	3.9	3.9
Dimethyl Fumarate	37	3.7	3.7
Conjugated Estrogens And Medroxyprogesterone Acetate	7	3.6	3.6
Pseudoephedrine Hydrochloride	3	3.6	3.6
Pseudoephedrine Hcl	3	3.3	3.3
Hydrocodone Bitartrate	8	2.3	2.3
Valbenazine	3	1.5	1.5

Related reactions

Data source: openFDA FAERS. See the OpenPV methodology and limitations.